| For: | Sierra L, Abu-Hammour MN, Chatterjee A, Simons-Linares CR. Obesity paradox role in the immunosuppressive treatment of hepatocellular carcinoma. World J Gastroenterol 2025; 31(19): 105617 [PMID: 40497086 DOI: 10.3748/wjg.v31.i19.105617] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v31/i19/105617.htm |
| Number | Citing Articles |
| 1 |
Yi-Kang Wang, Hua-Guo Feng, Yan-Han Liu, Chun-Yu Zhang, Xue Zhou, Hai-Ling Liu, Zuo-Jin Liu, Hao-Yang Tan. A simplified MRI‑based risk score and nomogram to predict initial objective response in unresectable hepatocellular carcinoma treated with HAIC, targeted therapy, and immunotherapy: a multicenter study. Abdominal Radiology 2026; doi: 10.1007/s00261-026-05732-6
|
| 2 |
Tao Zhang, Xue Li, Yingli Guo, Junsong Zeng, Maosen Xu, Yan Tie. AI-Driven Radiomics Assisted Prognostic Modeling for Hepatocellular Carcinoma with Portal Vein Invasion: A Retrospective Study. Biomedicines 2026; 14(9) doi: 10.3390/biomedicines14091894
|
| 3 |
Yihang Cai, Junyi Jin, Yihui Wang, Dongchen Han, Xinmiao Yu, Feng Jin, Mu Li, Yang Li, Xiaoying Li. Obesity-derived metabolites modulate anti-tumor immunity in the tumor microenvironment: from mechanisms to clinical applications. BMC Medicine 2026; 24(1) doi: 10.1186/s12916-026-04898-6
|
| 4 |
Maho Egusa, Issei Saeki, Yasuto Takeuchi, Shigeo Shimose, Takanori Ito, Joji Tani, Ryu Sasaki, Kyo Sasaki, Takeshi Hatanaka, Takaya Suzuki, Rintaro Kobayashi, Satoru Kakizaki, Norikazu Tanabe, Sohji Nishina, Hisamitsu Miyaaki, Hideki Kobara, Hiroki Kawashima, Takumi Kawaguchi, Motoyuki Otsuka, Takahiro Yamasaki, Taro Takami. Concurrent low skeletal muscle mass and fat area may predict poor survival in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy. Clinical Nutrition ESPEN 2026; 75 doi: 10.1016/j.clnesp.2026.105040
|